uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Life, death ant the role of IGF-I in human multiple myeloma
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Genetics and Pathology.
1998 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Multiple myeloma (MM) is a clonal expansion of malignant cells with a plasmablast- plasma cell morphology in the bone marrow. It is a fatal disease with a median survival of 2-3 years after start of conventional therapy. The aim of the thesis was to study the regulation of growth and survival of MM cell lines and primary, cells to identify potential targets for therapy. The results of the thesis show that MM cells express IGF-I (insulin-like growth factor-I) receptors and IGF-I. Furthermore, IGF-I was shown to stimulate growth and survival of MM cells. When IGF-IR signaling is inhibited by anti-IGF-IR antibodies in MM cells they are growth inhibited and may also undergo apoptosis. The somatostatin analogue octreotide has been demonstrated to interfere with the action of IGF-I. The results of the thesis show that MM cells express sst2, sst3 and sst5 which bind octreotide with a moderate or high affinity. Moreover, octreotide inhibits the growth of all investigated MM clones. In a few cases growth inhibition was also accompanied by the induction of apoptosis.

Resistance to apoptosis may be important for cell survival and drug resistance in MM clones. Studies in the thesis demonstrated that interferon (IFN)-α and IFN-γ augment the sensitivity to Fas-induced apoptosis in MM cells independently of their growth inhibitory effect. The sensitivity to apoptosis was also increased by inhibition of IGF-IR signaling. Incubation of MM cells with anti-IGF-IR antibodies increased the sensitivity of the cells to apoptosis induced by Fas ligation and the glucocorticoid dexamethasone.

It can be concluded that the IGF-IR may be a potential target for therapy in MM. Furthermore, increasing the sensitivity of MM cells to apoptosis by treatment with IFNs or drugs that interfere with the action of IGF-I may increase the sensitivity of the tumor cells to cytotoxic drugs.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis , 1998. , [4], 79 p.
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 0282-7476 ; 808
Keyword [en]
Genetics, Multiple Myeloma, IGF-I, apoptosis, Fas, glucocorticoids, somatostatin
Keyword [sv]
National Category
Medical Genetics
Research subject
URN: urn:nbn:se:uu:diva-269ISBN: 91-554-4356-7OAI: oai:DiVA.org:uu-269DiVA: diva2:162049
Public defence
1999-01-22, Fåhraeussalen, Dep., of Genetics and Pathology, Uppsala University, Uppsala, 09:15
Available from: 1999-01-01 Created: 1999-01-01Bibliographically approved

Open Access in DiVA

No full text
Buy this publication >>

By organisation
Department of Genetics and Pathology
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 68 hits
ReferencesLink to record
Permanent link

Direct link